God is our Guide                 Number 1 site for helping reverse diseases on Planet Earth
cidpUSA Foundation

 cidpusa.org   

      

 
      Home
      Diagnosis
      Treatment
      Pathology
      Variants
      CIDP info
      Fibromyalgia
      IVIG
      Diet anti-inflammatory
      Burning  Feet Home
      Services Page
      Chronic Fatigue
      Autoimmune diseases
      Prognosis
      Bible healing
      Celiac disease
Autoimmune self attack

CMT

Miracle ITP

Hemolytic anemia

Cholesterol drugs & Bleeding

What is autoimmune

Toxic Baby products

Infants  and women omega-3

 Selenium

Basil

Bay leaves

Eliminate insulin implants

Sugar treatment

Heart FAILURE

Irregular periods

Myasthenia diet

Prophets

cancer survivor

Tomato as a medicine

New Vaccine
  Natural Makeup
  Neck Pain
  Ocular Female diseases
  Chronic fatigue syndrome
  Osteoporosis
  Women Heart Attacks
  Breast Size & Disease
  Female Sex Disease
  PARKINSON
  Memory problems
  Breast Lymph Drainage
  Kidney stone Buster
 Bras cause breast cancer
  Skin repair Clinic
 Pandas
  Hepatitis

Risk of heart disease & stroke 

Depression and breast cancer

Kidney stone removal 

Alopecia general

Personality

Skin hair nail spa

Memory clinic

Depression & anxiety

Addiction  & Drug Rehab

Sexual  disorders Clinic

Parkinson Clinic

Epilepsy Clinic

Pain Clinic

Bone disorders clinic

Joint disorder clinic

Neurology Clinic

TMJ Clinic

Reduce  your weight

Antibiotics

 Vitiligo

DHEA and cognitive functions

Parkinson

Diabetise-2

Body goes against the grain

Anemia and celiac disease

ITP

  Complete  guide on alternatives treatment of autoimmune disease please read our e-book 

 

 

 

      

Intravenous Immunoglobulin Is Effective Therapy for Acute Idiopathic Thrombocytopenic Purpura

 

Read about the miracle cure of ITP under cidpusa guidance

Pylori + AITP

Question

  • In otherwise healthy children with acute onset idiopathic thrombocytopenic purpura (ITP), does treatment with IVIG versus no treatment result in more rapid resolution?

Clinical Bottom Lines

  1. High doses of IVIG and prednisone can produce a rapid increase in platelet counts in children with acute ITP and platelet counts under 20,000 (those at high risk for intracranial hemorrhage).
  2. The rate of platelet count response was significantly faster in those given treatment, and most rapid for those given immunoglobulin.
  3. Two patients (NNT=2) would have to be treated with IVIG compared to no treatment in order to have one whose platelet count rose above 50,000 in less than 3 days.  Three patients (NNT=3) would have to be treated with IVIG compared to prednisone for the same outcome.
 


Summary of Key Evidence

  1. A randomized trial of 53 patients compared intravenous immune globulin G (IVIG), oral prednisone, and placebo in the treatment of acute ITP.1
  2. Nineteen patients received IVIG at 1 gm/kg daily for two days, 18 received prednisone at a dose of 4 mg/kg (tapered over 21 days), and 16 received no therapy.  Baseline clinical characteristics were similar for all three groups.  The administration of drugs was not blinded.
  3. Prior to randomization, subjects were stratified by severity of hemostatic defect.  Inclusion criteria included: age over 6 months and under 18 years; platelet count less than 20,000; a bone marrow aspirate consistent with ITP; and no evidence of chronic ITP.
  4. Primary outcomes for the study were: number of days with a platelet count under 20,000 and the number of days required to reach a platelet count over 50,000.  Secondary outcomes were the occurrence of any adverse effect of therapy.
  5. Median duration of severe thrombocytopenia after treatment was 1 day for IVIG (p<0.001) and 2 days for prednisone (p<0.01) compared to 4 days for no therapy.  Results between the two treatment groups were not significantly different.
  6. The median time to reach a platelet count above 50,000 was 2 days for those in the IVIG group (statistically different than both prednisone and no therapy)
  7. Seventy-five percent of those treated with IVIG had some combination of nausea, vomiting, headache, and fever.  The most common adverse reaction to prednisone was weight gain.

 

Additional Comments

  • The main reason for treating children with acute ITP is the prevention of intracranial hemorrhage (ICH), a complication that occurs in 1% of affected children.  Randomized studies would require prohibitively large numbers of patients in order to use this as an outcome of interest.
  • Given that acute ITP in childhood is usually self-limited disease, the inclusion of a no-therapy group in this study is helpful (and rather unique among other published studies).  Both therapies performed better than no therapy.
  • Cost and availability of IVIG are important considerations.

Citation

  1. Blanchette VS, Luke B, Andrew M, et al.  A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura.  J Pediatr 1993; 123:989-95.

    www.cidpusa.org  www.cidpusa.org/P/ivig.htm  http://www.cidpusa.org/disease.html http://www.cidpusa.org/Lahore.html

         Melbourne    Avoid an episiotomy    Celiac Disease   Spice Names   transplant treatment   DiabeticTreatment  Bay Leaves   More Spices  7 Habits of Covy   MagneticFieldMap

         NanoMedicine   managed Care   MS GENES   Polymyalgia   Achalasia   u stay young  Autonomic  Quranic Shifa   Mercury in makeup   Toxic Lipstick

 

          Hypothyroid Infections help children

 

 

 

 

 

 


 

 
 

  

  

IgG

IgA 

Immune dysfunction

IgG subclass deficiency 

Immunodeficiency

 Immune deficiency

IgA nepropathy

911 CIDP story

Tetanus Vaccine Story

Stem Cell Story

Surgery CIDP

Cranial nerve CIDP

Farmer CIDP

Recurrent attack CIDP

Charcot

Car accident & CIDP

Arthritis & CIDP

Flu Shot Story

MS & CIDP story

Story21new

Renal transplant PRA

Neck Pain Tips

 Quran page